Holen Sie sich die Stockscreener-App
7.275
2.94%
-0.215
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$7.49
Offen:
$7.47
24-Stunden-Volumen:
1.45M
Relative Volume:
0.67
Marktkapitalisierung:
$2.69B
Einnahmen:
$9.47B
Nettoeinkommen (Verlust:
$-178.00M
KGV:
-15.16
EPS:
-0.48
Netto-Cashflow:
$1.01B
1W Leistung:
-9.35%
1M Leistung:
+7.39%
6M Leistung:
-3.58%
1J Leistung:
+23.85%
1-Tages-Spanne:
$7.25
$7.55
1-Wochen-Bereich:
$7.25
$8.02
52-Wochen-Spanne:
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Vergleichen Sie BHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.265 | 2.97B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
155.15 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.11 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.685 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.27 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
305.74 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Layoff Tracker: Opthea Slashes 80% of Workforce, 50% of Board - BioSpace
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
Bausch Health (BHC) Climbs 45% on Insider Buying - MSN
Myositis Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Roche, Pfizer, Zydus Group, Lupin, Bausch Health, Accord Healthcare, Genentech - Barchart.com
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Paulson increases ownership of Bausch Health common shares - MSN
Bausch Health Pick of the Week at Smart Insider Following Non-Executive Chair Paulson's Stock Purchase - MarketScreener
Bausch Health rises after $300M worth insider purchase (update) - MSN
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting - MSN
Icahn representations resign Bausch + Lomb board after agreement termination - Reuters
Icahn representatives resign from Bausch + Lomb board as agreement ends By Investing.com - Investing.com Nigeria
Bausch + Lomb board members resign after Icahn agreement ends - Reuters
Strategic Governance Shifts and Shareholder Value at Bausch + Lomb and Bausch Health: A New Era of Stability and Confidence - AInvest
Icahn representatives resign from Bausch + Lomb board as agreement ends - Investing.com
Bausch + Lomb Announces Board Changes - The Globe and Mail
Major Board Shake-up: Icahn Representatives Exit Bausch + Lomb Board as Ownership Falls Below Threshold - Stock Titan
Icahn Group Exits Bausch Boards As Paulson Steps In - Finimize
Does Paulson’s Larger Stake in Bausch Health (BHC) Signal a Shift in Strategic Priorities? - simplywall.st
Bausch Health rises after $300M worth insider purchase - MSN
What makes Bausch Health Companies Inc. stock price move sharply2025 Market Sentiment & Weekly Setup with ROI Potential - sundaytimes.kr
Bausch Health Companies Inc. (NYSE:BHC) Stock Catapults 30% Though Its Price And Business Still Lag The Industry - 富途牛牛
Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified - simplywall.st
Options Data Show Bullish Bias in Bausch Health Companies Inc.Trade Risk Report & Weekly Stock Performance Updates - sundaytimes.kr
Visualizing Bausch Health Companies Inc. stock with heatmapsMarket Performance Recap & Long-Term Safe Return Strategies - Newser
Trend analysis for Bausch Health Companies Inc. this weekProduct Launch & Daily Profit Maximizing Tips - Newser
Bausch Health Cos (NYSE:BHC) Shares Gap Up on Insider Buying Activity - Defense World
Bausch Health's Shareholder Shift: Strategic Implications for Governance and Shareholder Value - AInvest
Bausch Health Announces Increase in Shareholding by Its Chairperson of the Board and Board Changes - 富途牛牛
Bausch Health Stake Rises for Paulson Capital; Brett Icahn and Steven Miller Resign as Board Directors - MarketScreener
Bausch Health stock soars after Paulson increases stake By Investing.com - Investing.com Australia
Bausch Health stock soars after Paulson increases stake - Investing.com
Bausch Health stock rises on insider purchase (BHC:NYSE) - Seeking Alpha
BHC Stock Price and Chart — TSX:BHC - TradingView
Bausch Health Brief: Brett M. Icahn and Steven D. Miller Have Resigned from the Board of Directors - MarketScreener
Bausch Health Brief: Announcing that Paulson Capital and Certain Affiliates and Managed Funds Have Increased Their Ownership of Company's Common Shares - MarketScreener
Bausch Health Brief: Announcing Increase in Shareholding by its Chairperson of the Board and Board Changes - MarketScreener
Paulson Capital increases stake in Bausch Health to 19.13% By Investing.com - Investing.com Nigeria
Bausch Health's Shareholder and Board Shake-Up: A Strategic Inflection Point for Value Creation? - AInvest
Paulson Capital increases stake in Bausch Health to 19.13% - Investing.com
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes - ACCESS Newswire
19.13% Ownership Stake: Bausch Health Chairman Paulson Acquires Icahn's Entire Position in Major Shakeup - Stock Titan
Bausch Health’s Strong Q2 Results: What’s Next? - StocksToTrade
Bausch Health Companies shares rise 3.93% intraday after acquiring DURECT Corporation for $63 million and director Paulson John's stock purchase. - AInvest
Bausch Health's Insider Purchase: A Strategic Indicator for Value Investors - AInvest
What is Bausch Health Companies Inc.’s TAM (Total Addressable Market)Inflation Watch & High Accuracy Trade Alerts - sundaytimes.kr
Toronto stocks subdued as investors await pivotal US-Russia meet - MarketScreener
Bausch Health Companies Stock (BHC) Opinions on Insider Buying and Acquisition News - Quiver Quantitative
Paulson John buys $312 million in Bausch Health (BHC) shares By Investing.com - Investing.com Australia
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):